Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Genedrive ( (GB:GDR) ) has shared an update.
Genedrive PLC has successfully completed its RetailBook Offer, raising approximately £226,308.92 through the issuance of 15,087,261 new Ordinary Shares at 1.5 pence per share. This fundraising effort, part of a larger initiative that raised a total of approximately £1.23 million, will see the new shares admitted to trading on AIM, enhancing the company’s capital base and potentially strengthening its market position.
More about Genedrive
Genedrive PLC operates in the healthcare industry, focusing on point-of-care pharmacogenetic testing. The company is known for its innovative solutions that enable rapid genetic testing, which is crucial for personalized medicine and improving patient outcomes.
YTD Price Performance: -35.92%
Average Trading Volume: 3,120,529
Technical Sentiment Signal: Strong Buy
Current Market Cap: £8.53M
Learn more about GDR stock on TipRanks’ Stock Analysis page.